Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Dec 23, 2022

Accession no.
0001209191-22-062647
Filed
Dec 23, 2022
Trade date
Nov 1-30, 2022
Filing delay
52 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $995.6. It was filed 52 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2022Common StockPPurchaseAcquired+20$2.53+$50.618,808Direct
Nov 2, 2022Common StockPPurchaseAcquired+20$2.54+$50.818,828Direct
Nov 3, 2022Common StockPPurchaseAcquired+20$2.44+$48.818,848Direct
Nov 4, 2022Common StockPPurchaseAcquired+20$2.42+$48.418,868Direct
Nov 7, 2022Common StockPPurchaseAcquired+20$2.45+$4918,888Direct
Nov 8, 2022Common StockPPurchaseAcquired+20$2.42+$48.418,908Direct
Nov 9, 2022Common StockPPurchaseAcquired+20$2.37+$47.418,928Direct
Nov 10, 2022Common StockPPurchaseAcquired+20$2.37+$47.418,948Direct
Nov 11, 2022Common StockPPurchaseAcquired+20$2.32+$46.418,968Direct
Nov 14, 2022Common StockPPurchaseAcquired+20$2.32+$46.418,988Direct
Nov 15, 2022Common StockPPurchaseAcquired+20$2.35+$4719,008Direct
Nov 16, 2022Common StockPPurchaseAcquired+20$2.31+$46.219,028Direct
Nov 17, 2022Common StockPPurchaseAcquired+20$2.29+$45.819,048Direct
Nov 18, 2022Common StockPPurchaseAcquired+20$2.27+$45.419,068Direct
Nov 21, 2022Common StockPPurchaseAcquired+20$2.38+$47.619,088Direct
Nov 22, 2022Common StockPPurchaseAcquired+20$2.37+$47.419,108Direct
Nov 23, 2022Common StockPPurchaseAcquired+20$2.29+$45.819,128Direct
Nov 25, 2022Common StockPPurchaseAcquired+20$2.31+$46.219,148Direct
Nov 28, 2022Common StockPPurchaseAcquired+20$2.37+$47.419,168Direct
Nov 29, 2022Common StockPPurchaseAcquired+20$2.34+$46.819,188Direct
Nov 30, 2022Common StockPPurchaseAcquired+20$2.32+$46.419,208Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)